ASNS and acute lymphoblastic leukemia: The dysregulation of asparagine synthetase (ASNS) expression in childhood acute lymphoblastic leukaemia (ALL) cells is considered to increase cell susceptibility to the toxicity of l-asparaginase (ASNase), a first-line therapy for ALL that breaks down asparagine1–3.